Pericarditis Market Insights:
In a recent research report by Market Research Community, the pericarditis market is expected to surpass USD 5.05 Billion by the year 2030, from USD 3.2 Billion in 2021.
Pericarditis is the inflammation of the thin- two-layered tissue sac called pericardium which holds the heart in place to help it function properly. The pericarditis cases are mild and improve on their own without the need for medical intervention. The symptoms of pericarditis are leg or abdominal swelling, cough, heart palpitations, low-grade fever, feeling sick or fatigued, shortness of breath when reclining on the back, piercing chest pain, and an overall sense of weakness.
The echocardiogram is anticipated to witness substantial growth over the forecast period mainly due to the precise imaging of heart diseases using sound waves and the reduction of risks associated with cardiotoxicity.
Based on region, Europe is expected to have the second largest market share in the increased growth of the pericarditis market in the forecast period. The factors such as the increased healthcare infrastructure development and the rising burden of rheumatoid arthritis (RA) are the major contributors to the growth of the pericarditis market in the region.
The market is projected to grow at a significant pace reaching a CAGR of approximately 5.2%, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally.
The study is consolidated into major segments and further into sub-segments, such as by type (acute, recurrent, chronic, and idiopathic), by diagnosis (electrocardiogram (ECG), echocardiogram, computerized tomography (CT), and x-ray), by treatment (medication (non-steroidal anti-inflammatory drugs (NSAIDs) and colchicine) and surgical treatment), by end-use (hospitals & clinics, ambulatory surgical centers, and academic & research institutes), to forecast the pericarditis market size by value; also includes the analysis of past market dynamics from 2016 – 2021, considering 2021 as the base year.
Lastly, the report includes a regional analysis and country analysis with the latest trends, along with the major key players including Johnson & Johnson Services, Inc., Novartis International AG., PerkinElmer Inc., AstraZeneca Plc., Bayer, Reckitt Benckiser, Fujifilm, Merck Sharp, and Dohme, Allergan Plc., Pfizer Inc.
Our Recently Published Report:
- https://theavtar.com/read-blog/12896
- https://ai.wiki/read-blog/27735
- http://social.marksedgwick.net/blogs/16057/Surgical-Microscopes-Market-Is-Estimated-To-Rise-In-The-Near
- https://app.socie.com.br/read-blog/5866
- https://blacksocially.com/read-blog/71223
- https://blog.storymirror.com/read/qs_ux1m5/oncology-information-systems-market
Contact:
Market Research Community
Email: sales@marketresearchcommunity.com
https://marketresearchcommunity.com
Contact no.: (US) +1-214-272-0393
(UK) +44-20-8133-9198
